[go: up one dir, main page]

GB202308906D0 - Treatment of trbc1-positive T cell malignancies - Google Patents

Treatment of trbc1-positive T cell malignancies

Info

Publication number
GB202308906D0
GB202308906D0 GBGB2308906.3A GB202308906A GB202308906D0 GB 202308906 D0 GB202308906 D0 GB 202308906D0 GB 202308906 A GB202308906 A GB 202308906A GB 202308906 D0 GB202308906 D0 GB 202308906D0
Authority
GB
United Kingdom
Prior art keywords
trbc1
positive
treatment
cell malignancies
malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2308906.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autolus Ltd
Original Assignee
Autolus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autolus Ltd filed Critical Autolus Ltd
Priority to GBGB2308906.3A priority Critical patent/GB202308906D0/en
Publication of GB202308906D0 publication Critical patent/GB202308906D0/en
Priority to PCT/GB2024/051514 priority patent/WO2024256823A1/en
Priority to PCT/GB2024/051515 priority patent/WO2024256824A1/en
Ceased legal-status Critical Current

Links

GBGB2308906.3A 2023-06-14 2023-06-14 Treatment of trbc1-positive T cell malignancies Ceased GB202308906D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2308906.3A GB202308906D0 (en) 2023-06-14 2023-06-14 Treatment of trbc1-positive T cell malignancies
PCT/GB2024/051514 WO2024256823A1 (en) 2023-06-14 2024-06-13 Treatment of trbc1-positive t cell malignancies
PCT/GB2024/051515 WO2024256824A1 (en) 2023-06-14 2024-06-13 Chimeric antigen receptors directed against trbc1 and trbc2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308906.3A GB202308906D0 (en) 2023-06-14 2023-06-14 Treatment of trbc1-positive T cell malignancies

Publications (1)

Publication Number Publication Date
GB202308906D0 true GB202308906D0 (en) 2023-07-26

Family

ID=87291457

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308906.3A Ceased GB202308906D0 (en) 2023-06-14 2023-06-14 Treatment of trbc1-positive T cell malignancies

Country Status (1)

Country Link
GB (1) GB202308906D0 (en)

Similar Documents

Publication Publication Date Title
IL316365A (en) Allogeneic t cells for treatment of hematological malignancies
EP3836935A4 (en) Treatment of b cell malignancies
ZA202107342B (en) Chiauranib for treatment of small cell lung cancer
EP4281063A4 (en) Oxabicycloheptanes for treatment of small cell lung cancer
GB202308906D0 (en) Treatment of trbc1-positive T cell malignancies
IL315441A (en) Methods of treating small cell lung cancer
IL315503A (en) Methods of treatment
IL316829A (en) Menin-mll inhibitors for the treatment of cancer
GB202201824D0 (en) Methods of treatment
GB202201825D0 (en) Methods of treatment
GB202201819D0 (en) Methods of treatment
HK40086210A (en) Treatment of b cell malignancies
GB202315695D0 (en) TReatment of cariomyopathy
GB202212506D0 (en) Treatment of covid-19
GB202311976D0 (en) Treatment of cancer
GB202218181D0 (en) Treatment of cancer
GB202201803D0 (en) Treatment of Cancer
GB202211632D0 (en) Treatment of water
IL320711A (en) Methods of treatment
GB202307686D0 (en) Treatment of conditions
GB202107994D0 (en) Treatment of cancer
GB202018062D0 (en) Treatment of cancer
GB202008037D0 (en) Treatment of cancer
IL320528A (en) Bcma-targeted car-t cell therapy of multiple myeloma
IL308377A (en) Methods of treating dermatomyositis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)